Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Syndulko

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Alcohol and Alcoholism (Oxford, Oxfordshire)|November 1, 1994
D2 dopamine receptor TaqI A alleles in medically ill alcoholic and nonalcoholic patientsE P Noble, K Syndulko, R J Fitch, et al.
Neurology|August 1, 1989
A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosisG W Ellison, L W Myers, M R Mickey, et al.
Annals of Neurology|October 23, 1997
Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task ForceR Rudick, J Antel, C Confavreux, et al.
Annals of Neurology|September 1, 1996
Clinical outcomes assessment in multiple sclerosisR Rudick, J Antel, C Confavreux, et al.
Brain : a Journal of Neurology|June 4, 1999
Development of a multiple sclerosis functional composite as a clinical trial outcome measureG R Cutter, M L Baier, R A Rudick, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Alcohol and Alcoholism (Oxford, Oxfordshire)|November 1, 1994
D2 dopamine receptor TaqI A alleles in medically ill alcoholic and nonalcoholic patientsE P Noble, K Syndulko, R J Fitch, et al.
Neurology|August 1, 1989
A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosisG W Ellison, L W Myers, M R Mickey, et al.
Annals of Neurology|October 23, 1997
Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task ForceR Rudick, J Antel, C Confavreux, et al.
Annals of Neurology|September 1, 1996
Clinical outcomes assessment in multiple sclerosisR Rudick, J Antel, C Confavreux, et al.
Brain : a Journal of Neurology|June 4, 1999
Development of a multiple sclerosis functional composite as a clinical trial outcome measureG R Cutter, M L Baier, R A Rudick, et al.
Pageof 7